| SYRS Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SYRS shares outstanding history going back to 6/30/2016:
Also see: SYRS Market Cap History SYRS YTD Return |
SYRS Shares Outstanding History — Syros Pharmaceuticals Share Count Over Time
As of 10/24/2024 Syros Pharmaceuticals has 26.83 million SYRS shares outstanding. Investors often track the SYRS shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows SYRS share count trends over time, with 35 historical shares outstanding datapoints presented, dating back to 6/30/2016.
| SYRS Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SYRS Historical Shares Outstanding: +34.50% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SYRS Stock Price Chart |
| About Syros Pharmaceuticals Inc |
| Syros Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing new treatments for hematologic malignancies. It is advancing Tamibarotene, a selective RARa agonist, in Phase III and Phase II trials for higher-risk myelodysplastic syndrome (HR-MDS) and acute myeloid leukemia (AML), respectively. Other assets include SY-2101 and SY-5609, with the latter being a potent CDK7 inhibitor for which the company is seeking out-licensing opportunities. We show 35 historical shares outstanding datapoints in our coverage of SYRS's shares outstanding history. Understanding the changing numbers of SYRS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SYRS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SYRS by allowing them to research SYRS shares outstanding history as well as any other stock in our coverage universe. |
| SYRS Current Stock Quote |
Quotes delayed 20 minutes  Free SYRS Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| SYRS Share Performance |
| Shares Outstanding Peers |
| Syros Pharmaceuticals (SYRS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
TALK Shares Outstanding History TALS Shares Outstanding History TAOX Shares Outstanding History TARA Shares Outstanding History TARO Shares Outstanding History TARS Shares Outstanding History TBIO Shares Outstanding History TCDA Shares Outstanding History TCMD Shares Outstanding History TCON Shares Outstanding History More Healthcare companies » |
SYRS Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
